Last edition
News about "EGFR/HER2 inhibitor"
ORIC Pharmaceuticals Signs Clinical Supply Deal with Janssen Research and Development
Under the terms of the agreement, ORIC® will conduct and sponsor the trial and Johnson & Johnson will provide SC amivantamab.
EGFR/HER2 Inhibitor | 15/01/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members